Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,645 | 15,816 | 8,910 | 14,056 | 17,880 |
| Marketable Securities | N/A | 28,083 | 12,959 | 15,200 | 31,415 |
| TOTAL | $21,210 | $46,077 | $24,298 | $31,889 | $50,151 |
| Non-Current Assets | |||||
| PPE Net | N/A | 51 | 81 | 5 | 29 |
| Intangibles | 0 | 108 | 123 | 137 | 471 |
| Other Non-Current Assets | 752 | 0 | 0 | 0 | 0 |
| TOTAL | $752 | $159 | $204 | $142 | $500 |
| Total Assets | $21,962 | $46,236 | $24,502 | $32,031 | $50,651 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,440 | 2,604 | 1,220 | 382 | 512 |
| Accrued Expenses | 891 | 5,371 | 3,391 | 2,441 | 1,850 |
| Other current liabilities | N/A | N/A | N/A | 27,349 | 30,430 |
| TOTAL | $4,331 | $7,975 | $4,611 | $30,172 | $32,792 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 47,262 | 0 | 0 | 0 | 30 |
| TOTAL | $47,262 | $N/A | $N/A | $N/A | $30 |
| Total Liabilities | $51,593 | $7,975 | $4,611 | $30,172 | $32,822 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 172 | 156 | 115 | 101 | 100 |
| Common Shares | 5 | 22 | 16 | 14 | 140 |
| Retained earnings | -31,384 | -561,637 | -531,198 | -513,474 | -494,771 |
| TOTAL | $-29,631 | $38,261 | $19,891 | $1,859 | $17,829 |
| Total Liabilities And Equity | $21,962 | $46,236 | $24,502 | $32,031 | $50,651 |